Describe the proportion of patients in whom the therapies are effective and whether we see durable responses in them as in sometimes the case with immune checkpoint inhibitors in other types of cancers.

Immunotherapy response prediction in gynaecological cancer.

Describe the proportion of patients in whom the therapies are effective and whether we see durable responses in them as in sometimes the case with immune checkpoint inhibitors in other types of cancers.

(5000 words long)